Gene · 55902
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An alcove at the acetyl-CoA synthase nickel active site is required for productive substrate CO binding and anaerobic carbon fixation. | J Biol Chem | 2024 | 38944127 | PubTator, text mining | PubMed |
| HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma. | J Clin Invest | 2024 | 38941296 | PubTator, text mining | PubMed |
| Brain Short-Chain Fatty Acids Induce ACSS2 to Ameliorate Depressive-Like Behavior via PPARγ-TPH2 Axis. | Research (Wash D C) | 2024 | 38939042 | PubTator, text mining | PubMed |
| miR-4443 Contained Extracellular Vesicles: A Factor for Endometriosis Progression by PI3K/AKT/ACSS2 Cascade in-vitro. | Int J Nanomedicine | 2024 | 38911502 | PubTator, text mining | PubMed |
| ACSS2 enables melanoma cell survival and tumor metastasis by negatively regulating the Hippo pathway. | Front Mol Biosci | 2024 | 38887280 | PubTator, text mining | PubMed |
| Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia. | Cancer Gene Ther | 2024 | 38851813 | PubTator, text mining | PubMed |
| Exploring the mechanisms of glycolytic genes involvement in pulmonary arterial hypertension through integrative bioinformatics analysis. | J Cell Mol Med | 2024 | 38837574 | PubTator, text mining | PubMed |
| Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation. | Dig Liver Dis | 2024 | 38824040 | PubTator, text mining | PubMed |
| Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells. | Front Pharmacol | 2024 | 38818373 | PubTator, text mining | PubMed |
| Reactivity of low-valent nickel carbonyl species supported by acridane based PNP ligands towards iodoalkanes. | Dalton Trans | 2024 | 38817194 | PubTator, text mining | PubMed |
| Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis. | Front Immunol | 2024 | 38742101 | PubTator, text mining | PubMed |
| Bioelectrochemical anaerobic digestion mitigates microplastic pollution and promotes methane recovery of wastewater treatment in biofilm system. | J Hazard Mater | 2024 | 38703685 | PubTator, text mining | PubMed |
| Validation of mitochondrial biomarkers and immune dynamics in polycystic ovary syndrome. | Am J Reprod Immunol | 2024 | 38661639 | PubTator, text mining | PubMed |
| Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. | Nat Cell Biol | 2024 | 38641662 | PubTator, text mining | PubMed |
| Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence. | Nat Commun | 2024 | 38615014 | PubTator, text mining | PubMed |
| N-glycosylation of SCAP exacerbates hepatocellular inflammation and lipid accumulation via ACSS2-mediated histone H3K27 acetylation. | Am J Physiol Gastrointest Liver Physiol | 2024 | 38591127 | PubTator, text mining | PubMed |
| Site specific redox properties in ligand differentiated di-nickel complexes inspired by the acetyl CoA synthase active site. | Dalton Trans | 2024 | 38591102 | PubTator, text mining | PubMed |
| Protein crotonylation: Basic research and clinical diseases. | Biochem Biophys Rep | 2024 | 38586826 | PubTator, text mining | PubMed |
| Acetyl-CoA synthetase 2 contributes to a better prognosis for liver cancer by switching acetate-glucose metabolism. | Exp Mol Med | 2024 | 38528124 | PubTator, text mining | PubMed |
| Letter-to-the-editor on "Acetyl-CoA synthetase (ACSS2) does not generate butyryl- and crotonyl-CoA". | Mol Metab | 2024 | 38513934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55902/papers?page=10